HIVE vs MRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 16, 2026
HIVE
MRX
Investment Advisor Scores
MRX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HIVE | MRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 62.8931 | 8.7642 | MRX |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 130.5% | 55.1% | HIVE |
| Earnings Growth | -99.9% | 55.4% | MRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.6/100 | 52.2/100 | HIVE |
| Profit Margin | -49.9% | 10.6% | MRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HIVE
NeutralMixed signals - no dominant trend phase, RSI 42
MRX
MarkupPrice above SMA50, rising 50-day trend (7.8% over 20 days), RSI 53
Fundamentals Snapshot
| Metric | HIVE | MRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.5 | 11.2 |
| Trailing P/E | — | 14.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.3% | 0.6% |
| Gross Margin | 0.4% | 0.7% |
| Operating Margin | -0.8% | 0.1% |
| EPS | -0.78 | 4.60 |
| Dividend Yield | — | 0.01% |